Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial.

Exercise testing in severe emphysema: association with quality of life and lung function.

The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations.

Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.

Estimating pulmonary artery pressures by echocardiography in patients with emphysema.

Bridging the gap: the 34th Varaztad H. Kazanjian Memorial Lecture.

Sex differences in severe pulmonary emphysema.

Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema.

Loss of GFI1 impairs pulmonary neuroendorine cell proliferation, but the neuroendocrine phenotype has limited impact on post-naphthalene airway repair.

Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.

Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.

Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness.

The growth factor independence-1 transcription factor: new functions and new insights.

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group.

Predictors of mortality in patients with emphysema and severe airflow obstruction.